A randomized, placebo-controlled, phase 2 trial of laquinimod in primary progressive multiple sclerosis.
Giovannoni G, Knappertz V, Steinerman JR, Tansy AP, Li T, Krieger S, Uccelli A, Uitdehaag BMJ, Montalban X, Hartung HP, Pia Sormani M, Cree BAC, Lublin F, Barkhof F.
Giovannoni G, et al. Among authors: barkhof f.
Neurology. 2020 Aug 25;95(8):e1027-e1040. doi: 10.1212/WNL.0000000000010284. Epub 2020 Jul 10.
Neurology. 2020.
PMID: 32651286
Clinical Trial.